FibroBiologics (FBLG) Change in Cash (2023 - 2026)

FibroBiologics has reported Change in Cash for 4 years, with the latest figure at $2.0 million in Q2 2026.

• Change in Cash for Q2 2026 came in at $2.0 million, up 1042.13% year-over-year; the trailing twelve-month figure through Jun 2026 was -$5.3 million (down 285.58% YoY), and the FY2025 annual result was -$9.1 million, down 288.53% from the prior year.
• Change in Cash advanced to $2.0 million in Q2 2026, from -$3.4 million in the prior quarter.
• Over five years, Change in Cash peaked at $12.5 million in Q1 2023 and troughed at -$5.3 million in Q1 2025.
• A 4-year average of $89214.3 and a median of -$808500.0 in 2023 frame the typical range for Change in Cash.
• The widest annual swing landed in 2025, when Change in Cash plunged 429.15%; it then soared 1042.13% in 2026.
• A 4-year view of Change in Cash shows it stood at -$1.6 million in 2023, then surged by 484.15% to $6.2 million in 2024, then tumbled by 99.56% to $27000.0 in 2025, then surged by 7429.63% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $2.0 million in Q2 2026, -$3.4 million in Q1 2026, and $27000.0 in Q4 2025.